secwatch / observer
8-K filed August 14, 2023, 7:59 PM ET ticker MTVA CIK 0001638287
leadership confidence high sentiment neutral materiality 0.90

NeuroBo Pharmaceuticals appoints Hyung Heon Kim as Chief Executive Officer and President

MetaVia Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Hyung Heon Kim

Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
MTVA · MetaVia Inc.
Effective
2023-08-11
Filed
August 14, 2023, 7:59 PM ET
appointed Mr. Hyung Heon Kim, a member of the Board, as the Company’s Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer effective as of August 11, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hyung Heon Kim was appointed as Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer at MetaVia Inc..

Action
appointed
Role
Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
Exact text from the filing
appointed Mr. Hyung Heon Kim, a member of the Board, as the Company’s Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer effective as of August 11, 2023.
View on SEC.gov

MetaVia Inc. filing history →

Source: SEC EDGAR
accession 0001558370-23-014716
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.